Plasma cholesterol efflux capacity from human THP-1 macrophages is reduced in HIV-infected patients: impact of HAART - Wikidata - awgldk - TriplyDB

Plasma cholesterol efflux capacity from human THP-1 macrophages is reduced in HIV-infected patients: impact of HAART

Plasma cholesterol efflux capacity from human THP-1 macrophages is reduced in HIV-infected patients: impact of HAART

http://www.wikidata.org/entity/Q35120957

about

Inflammation, immune activation, and cardiovascular disease in HIV.Pathophysiology and management of cardiovascular disease in patients with HIV Association of Cholesterol Efflux Capacity With Clinical Features of Metabolic Syndrome: Relevance to Atherosclerosis.Metabolic and Cardiovascular Complications in HIV/HCV-Co-infected Patients.HDL Cholesterol Efflux Capacity in Newly Diagnosed HIV and Effects of Antiretroviral Therapy.Cholesterol efflux responds to viral load and CD4 counts in HIV+ patients and is dampened in HIV exposed Insulin Resistance in HIV-Patients: Causes and Consequences

P2860

Q36957752-B2859797-BBC2-45F0-83A8-874B3E428B41 Q37038775-0737CEBE-FE12-4B94-ADCF-2F2465EAA5E9 Q37556265-731940A2-A4D4-4AD1-8609-6EF52AF492CC Q38946641-B86EBEC3-45ED-468C-A496-B3DBE3A058DB Q46224865-0BC2B3C8-6DA8-4300-9F68-28EF7F7AB372 Q58741972-67DE4E26-F8A6-4BE5-B28D-6C79FB6836FA Q58763014-E3171ED3-1B10-46F7-BE7C-972A043B465B

P2860

Plasma cholesterol efflux capacity from human THP-1 macrophages is reduced in HIV-infected patients: impact of HAART

http://www.wikidata.org/entity/Q35120957

description

2015 nî lūn-bûn

@nan

2015 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Plasma cholesterol efflux capa ...... cted patients: impact of HAART

@ast

Plasma cholesterol efflux capa ...... cted patients: impact of HAART

@en

type

label

Plasma cholesterol efflux capa ...... cted patients: impact of HAART

@ast

Plasma cholesterol efflux capa ...... cted patients: impact of HAART

@en

prefLabel

Plasma cholesterol efflux capa ...... cted patients: impact of HAART

@ast

Plasma cholesterol efflux capa ...... cted patients: impact of HAART

@en

P1433

Q35120957-47B057D2-6A90-4005-A0D4-036BB1CF37EE

P1476

Q35120957-C5C3AF20-B019-4373-8CBF-ACF828038BFC

P2093

Q35120957-22B79C62-F47C-4120-A8E8-C47B4C05F4B1

Q35120957-4693FA76-A3B7-45A3-9BB2-8B7C03CC896E

Q35120957-4B65C12C-8F5E-4F6D-8F9A-DEB096A331DB

Q35120957-4E4C10E1-D8BC-4712-9C8A-545746408A24

Q35120957-62AEE661-0187-4148-9C11-17E0C024C21F

Q35120957-9D5A1C7E-30BA-4ACC-B25B-A14F58D649E6

Q35120957-A08FFFEC-E13B-4D80-AEE7-830A79207CF6

Q35120957-A3A9D1DE-E20E-40F5-B8BB-75DEB4A18CFA

P2860

Q35120957-0027385E-2645-4E81-9412-F64213EAFB7D

Q35120957-00B512C2-A7F5-4999-9667-76A517B53EED

Q35120957-032C8BB2-8471-40CD-AAEE-7B55EA714947

Q35120957-0A323EC3-63E5-4E0B-BAE6-B19CFDDEE0F9

Q35120957-0E45C999-5169-4501-8627-50DA14822A74

Q35120957-139C31C3-8617-4820-91A2-BC136B9737CC

Q35120957-1504C1F8-C06C-4347-A254-6C900D96BB04

Q35120957-17E5EAAB-0235-4D35-9186-1104527AD51E

Q35120957-184C4F35-93B2-4572-B6E3-E2BC06788687

Q35120957-19E685C6-8992-459B-A185-96107685BD04

P304

Q35120957-1EDA03AD-55DF-406E-AAE0-125A047EC42F

P31

Q35120957-103E119F-3EF6-4BC4-8AE7-10C58970319E

P356

Q35120957-F62DD78E-A9FB-4F7B-9D79-19BDA995A1AD

P433

Q35120957-CAE68793-441C-45AA-BB3B-BC69A8BBC949

P478

Q35120957-BDCE21B5-51DB-47C8-9A97-509276CE257E

P50

Q35120957-A1B8ABA7-00BE-4FE4-9C0C-F6764A66D748

Q35120957-CA0A786E-26DC-4B9D-AB82-EC675665C0A2

P577

Q35120957-3EF7AE92-270F-4144-A78A-3CB855CC05DD

P698

Q35120957-52DAA9BE-A133-4596-892F-88DAD2735BAA

P932

Q35120957-80807C03-795A-4CE7-A45B-4B02EEA03565

P356

P1433

Journal of Lipid Research

P1476

Plasma cholesterol efflux capa ...... cted patients: impact of HAART

@en

P2093

Corinne Vigouroux

http://www.w3.org/2001/XMLSchema#string

Cécile Goujard

http://www.w3.org/2001/XMLSchema#string

Elise F Villard

http://www.w3.org/2001/XMLSchema#string

Laurence Meyer

http://www.w3.org/2001/XMLSchema#string

Maryse Guerin

http://www.w3.org/2001/XMLSchema#string

Mathilde Ghislain

http://www.w3.org/2001/XMLSchema#string

Patrick Yeni

http://www.w3.org/2001/XMLSchema#string

Petra El Khoury

http://www.w3.org/2001/XMLSchema#string

P2860

LXR-induced redistribution of ABCG1 to plasma membrane in macrophages enhances cholesterol mass efflux to HDL

ABCA1-mediated transport of cellular cholesterol and phospholipids to HDL apolipoproteins

ATP-binding cassette transporters G1 and G4 mediate cellular cholesterol efflux to high-density lipoproteins

CD4+ count-guided interruption of antiretroviral treatment

Human immunodeficiency virus impairs reverse cholesterol transport from macrophages.

Lipoprotein particle subclasses, cardiovascular disease and HIV infection.

HIV, HAART, and lipoprotein particle concentrations in the Women's Interagency HIV Study.

Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis.

Changes in lipids and lipoprotein particle concentrations after interruption of antiretroviral therapy.

Cytokines and HIV-1: interactions and clinical implications.

P304

692-702

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1194/JLR.M054510

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

56

http://www.w3.org/2001/XMLSchema#string

P50

Caroline Lascoux-Combe

Wilfried le Goff

P577

2015-01-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25573889

http://www.w3.org/2001/XMLSchema#string

P932

4340316

http://www.w3.org/2001/XMLSchema#string